ResearcherCharles UniversityActive in the last 2 years
Bohuš Bunganič
Matched on ORCID iD 0000-0002-2870-7003; OpenAlex author ID A5052541722. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 3, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2014: 1 paper · 2015: none · 2016: 3 papers · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 11
- Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Cancer. First author DOI 10.3390/genes15101302↗
- Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. Co-author DOI 10.3390/cancers15143669↗
- Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics. Last author DOI 10.1021/acs.jproteome.0c00990↗
- Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer. Co-author DOI 10.1007/s12253-018-0490-9↗
- Chiroptical spectroscopy and metabolomics for blood-based sensing of pancreatic cancer. First author DOI 10.1002/chir.22834↗
- Precursors of pancreatic cancer. Co-author DOI 10.1097/meg.0000000000000810↗
- [Diagnosis of early pancreatic cancer and precursor lesions]. First author PMID 29063770↗
- Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.06.001↗
- Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers. Co-author DOI 10.1097/meg.0000000000000727↗
- [Early detection of sporadic pancreatic cancer]. Co-author PMID 26898791↗
- [Pancreatic adenocarcinoma - early symptoms and screening]. Co-author PMID 25561240↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Miroslav Zavoral · 10 shared papers, 2014–2024 · strength 1.05
- Paper Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Can… DOI 10.3390/genes15101302↗
- Paper Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. DOI 10.3390/cancers15143669↗
- Paper Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Test… DOI 10.1007/s12253-018-0490-9↗
- Jan Škrha · 5 shared papers, 2016–2023 · strength 0.43
- Tereza Hálková · 2 shared papers, 2020–2024 · strength 0.38
- Paper Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Can… DOI 10.3390/genes15101302↗
- Paper Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Test… DOI 10.1007/s12253-018-0490-9↗
- Marek Minárik · 2 shared papers, 2020–2024 · strength 0.38
- Paper Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Can… DOI 10.3390/genes15101302↗
- Paper Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Test… DOI 10.1007/s12253-018-0490-9↗
- Lucie Benešová · 2 shared papers, 2020–2024 · strength 0.38
- Paper Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Can… DOI 10.3390/genes15101302↗
- Paper Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Test… DOI 10.1007/s12253-018-0490-9↗
- Lucie Habartová · 3 shared papers, 2017–2021 · strength 0.33
- Paper Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics. DOI 10.1021/acs.jproteome.0c00990↗
- Paper Chiroptical spectroscopy and metabolomics for blood-based sensing of pancreatic cancer. DOI 10.1002/chir.22834↗
- Paper [Diagnosis of early pancreatic cancer and precursor lesions]. PMID 29063770↗
- Vladimı́r Setnička · 3 shared papers, 2017–2021 · strength 0.33
- Paper Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics. DOI 10.1021/acs.jproteome.0c00990↗
- Paper Chiroptical spectroscopy and metabolomics for blood-based sensing of pancreatic cancer. DOI 10.1002/chir.22834↗
- Paper [Diagnosis of early pancreatic cancer and precursor lesions]. PMID 29063770↗
- Premysl Fric · 5 shared papers, 2014–2017 · strength 0.31
- Pavel Škrha · 3 shared papers, 2016–2023 · strength 0.30
- Paper Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. DOI 10.3390/cancers15143669↗
- Paper [Early detection of sporadic pancreatic cancer]. PMID 26898791↗
- Paper Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers. DOI 10.1097/meg.0000000000000727↗
- Aleksi Šedo · 4 shared papers, 2016–2017 · strength 0.24
- Paper Precursors of pancreatic cancer. DOI 10.1097/meg.0000000000000810↗
- Paper [Early detection of sporadic pancreatic cancer]. PMID 26898791↗
- Paper Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ducta… DOI 10.1016/j.pan.2016.06.001↗
- Petr Bušek · 4 shared papers, 2016–2017 · strength 0.24
- Paper Precursors of pancreatic cancer. DOI 10.1097/meg.0000000000000810↗
- Paper [Early detection of sporadic pancreatic cancer]. PMID 26898791↗
- Paper Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ducta… DOI 10.1016/j.pan.2016.06.001↗
- Jan Bureš · 1 shared paper, 2023 · strength 0.19
- Lenka Michálková · 1 shared paper, 2021 · strength 0.16
- Tomáš Zima · 2 shared papers, 2016 · strength 0.11
- Martina Hrůzová · 1 shared paper, 2017 · strength 0.08
- Pavel Záruba · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.